26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
Maron
B J
BJ
Isner
J M
JM
McKenna
W J
WJ
D009202:Cardiomyopathies / Q000175:diagnosis*; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis*; D004608:Eligibility Determination; D006801:Humans; D008945:Mitral Valve Prolapse / Q000175:diagnosis*; D009205:Myocarditis / Q000175:diagnosis*; D010493:Pericarditis / Q000175:diagnosis*; D012306:Risk; D013177:Sports; D013178:Sports Medicine